Singapore, May 8, 2008: Wanbury, one of the fastest growing pharma companies in India and the largest supplier of Metformin, Tramadol and Salsalate in the US markets has announced that it has bagged ‘Best Launch Award’ for its success in C -Pink, an iron supplement for treatment of anemia especially for pregnant women and children.

 

C-Pink packaged as 50 mg tablets, is used for the treatment of IDA (Iron Deficiency Anemia) and caters to a market worth Rs 500 crore ($120.33 million). It boasts of the highest absorption levels compared to other iron supplements. C-Pink is one of the few formulations to have touched a turnover of Rs 12 crore ($2.89 million) in the year of launch itself and presently clocking annualized sales of over Rs 20 crore ($ 4.81 million).

 

C-Pink is now amongst the top 300 ethical formulation brands in India and is ranked at 186th. It has moved from the 89th overall position to 61st position over the last 12 months as per ORG IMS data

 

“The revamp of the human resource and the persistent efforts to reduce costs has finally paid off in terms of growth and we are proud to have found our way to the top. And this is just the beginning,” said Mr Ashok Shinkar, Director Corporate Finance, Wanbury Ltd.

 

The release noted that C-Pink is well accepted by gynecologists, pediatricians and general physicians. An all India presence and sales marketing team of over 400 personnel has contributed to making this a strong brand.